US Patent 9126941 Treatment of hyperproliferative disorders with diarylhydantoin compounds
All edits
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+211 characters)
Article
Patent abstract
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09126941 Treatment of hyperproliferative disorders with diarylhydantoin compounds US Patent 9126941 Treatment of hyperproliferative disorders with diarylhydantoin compounds
Infobox
Patent Number
091269410
Patent Number
91269410
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
091269410
Date of Patent
September 8, 2015
0Patent Application Number
134489640
Date Filed
April 17, 2012
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09126941 Treatment of hyperproliferative disorders with diarylhydantoin compounds
Infobox
Is a
Patent jurisdiction
Patent number
09126941
Date of patent
September 8, 2015
Patent application number
13448964
Date Filed
April 17, 2012
Patent primary examiner
Find more entities like US Patent 9126941 Treatment of hyperproliferative disorders with diarylhydantoin compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
